According to Yonhap News,
The city of Busan accommodates a head office of global R&D center. There was an MOU signing ceremony between Busan city and Amicogen on May 13, as part of city level investment to welcome a world class research center. Both parties outlined details of the KRW 11 million worth of pact, with a focus on construction project which comes to an end in 2025 on a 33,000㎡ business site.
They also unveiled a recruitment plan to add 116 new jobs, particularly to secure well educated human resources who will be deployed in collaborative research work with multiple entities involved.
A special enzyme producer, Amicogen, has started business since 2000 and successfully got it listed on Korea Securities Dealers Automated Quotations (KOSDAQ) showcasing its gene recombination technology to the market.
Copyrights Yonhap News. All Rights Reserved.
Reprint or redistribution without permission is prohibited.
Source: Yonhap News (May 13 , 2020)
** This article was translated from Korean.